Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04654117 · ClinicalTrials.gov registry record · NA

Examining the Active Ingredients of Consultation of a Parent-mediated Intervention for Autism

A NA study, sponsored by Michigan State University.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT04654117: Completed NA study, sponsored by Michigan State University.

NCT04654117 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04654117, a NA study, has completed, sponsored by Michigan State University.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

Parent-mediated interventions are considered best practice for treating children with autism spectrum disorder, but these interventions are underutilized in community settings. Implementation strategies like consultation can improve the implementation of these interventions, but little is known about the active ingredients of consultation. This study uses an experimental design (ABCD single-case design with multiple baselines) to identify the active ingredients of a consultation model designed to support the implementation of a parent-mediated intervention for autism spectrum disorder in a low-resourced community mental health system.

Primary Outcome

The Project ImPACT Coaching Fidelity Checklist is a measure of treatment adherence. It uses a 3-point scale -- Observed (1), Partially Observed (.5), and Not Observed (0). Higher scores indicate higher treatment adherence. Based on scoring guidelines for this measure, scores for each item are multiplied by an item-specific weight value. Scores for each item are then summed and divided by the total number of items scored, yielding a score ranging from 0 to 100.

Interventions

  • OTHER Consultee-centered administrative consultation

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2021-10-01
Est. Completion 2023-03-30
Phase NA
Michigan State University

120 total trials

What the finished NCT04654117 record still lists

NCT04654117 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Consultee-centered administrative consultation is the first listed.

NCT04654117 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04654117 about?

NCT04654117 is a clinical study titled "Examining the Active Ingredients of Consultation of a Parent-mediated Intervention for Autism". Parent-mediated interventions are considered best practice for treating children with autism spectrum disorder, but these interventions are underutilized in community settings. Implementation strategies like consultation can improve the implementation of these interventions, but little is known abou...

What is the current status of trial NCT04654117?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-10-01. Estimated completion is 2023-03-30.

What interventions are being tested in trial NCT04654117?

The interventions under investigation include: Consultee-centered administrative consultation (OTHER).

Who is sponsoring clinical trial NCT04654117?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04654117's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04654117, the US trial registry maintained by the National Library of Medicine. NCT04654117 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.